Excited to announce Aterian Investment Partners has entered into an agreement to recapitalize Contract Pharmaceuticals Limited! CPL is a leading provider of development, manufacturing, packaging, and testing of non-sterile liquid and semi-solid pharmaceutical products globally. #privateequity #mergersandacquisitions #pharmaceutical #CDMO
Aterian Investment Partners’ third healthcare manufacturing and first Canadian platform! Pumped to share Aterian has entered into an agreement to recapitalize Contract Pharmaceuticals Limited, a leading pharmaceutical contract development & manufacturing organization (CDMO). CPL provides development, manufacturing, packaging, and testing of non-sterile liquid and semi-solid pharmaceutical products. #privateequity #mergersandacquisitions #pharmaceutical #CDMO